Nanoform Finland (OSTO:NANOFS) Common Stock : kr0.90 Mil (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Nanoform Finland Common Stock?

Nanoform Finland's quarterly common stock increased from Jun. 2023 (kr0.93 Mil) to Sep. 2023 (kr0.95 Mil) but then declined from Sep. 2023 (kr0.95 Mil) to Dec. 2023 (kr0.90 Mil).

Nanoform Finland's annual common stock increased from Dec. 2021 (kr0.82 Mil) to Dec. 2022 (kr0.88 Mil) and increased from Dec. 2022 (kr0.88 Mil) to Dec. 2023 (kr0.90 Mil).

Nanoform Finland Common Stock Historical Data

The historical data trend for Nanoform Finland's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanoform Finland Common Stock Chart

Nanoform Finland Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Common Stock

Get a 7-Day Free Trial

0.03

0.81

0.82

0.88

0.90

Nanoform Finland Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Common Stock	Get a 7-Day Free Trial															0.88	0.90	0.93	0.95	0.90

Nanoform Finland Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Nanoform Finland (OSTO:NANOFS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nanoform Finland PLC (OSTO:NANOFS) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

NANOFH:Finland 4YL:Germany

Address

Cultivator II, Viikinkaari 4, Helsinki, FIN, 00790

Website

https://www.nanoform.com

Nanoform Finland PLC is a nanoparticle medicine-enabling company. The company works together with pharma and biotech partners to reduce attrition in clinical trials and enhance their molecules' formulation performance through its nano-forming services. Its patented and scalable Controlled Expansion of Supercritical Solutions (CESS) technology produces nano-formed API particles as small as 10nm. This enables poorly soluble molecules in the pharmaceutical pipeline to progress into clinical development by increasing their rate of dissolution and by improving their bioavailability. Its technology provides novel opportunities in many value-enhancing drug delivery applications.

Nanoform Finland (OSTO:NANOFS) Headlines

No Headlines